The number of drug injury lawsuits against Pfizer Inc. over its Lipitor medication continues to rise. Court documents indicate that in U.S. District Court, District of South Carolina, where federal multidistrict litigation is taking place, at least 2,185 Lipitor cases are pending.
In their Lipitor lawsuits, the plaintiffs contend that the drug company did not warn that the statin medication could up the risk of Type 2 A diabetes. It wasn’t until 2012 that the U.S. Food and Drug Administration said that all statin labels would have to be modified to include this information. Even then, claim the plaintiffs, Lipitor’s modified labels failed to warn patients about the connection between diabetes and the medication.
Statins are a category of drug that obstructs the liver’s production of cholesterol. This is supposed to lower the risk of heart disease.